NETAKIMAB
UNII D3IAG45DAK

Substance Identification & Data

This profile provides standardized clinical and technical data for Netakimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D3IAG45DAK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1796570-08-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
D3IAG45DAK
CAS Registry Number
1796570-08-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NETAKIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10387
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Netakimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NETAKIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 17) (HUMAN-LAMA GLAMA MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
NETAKIMAB [INN]
NETAKIMAB [WHO-DD]